The patient had a permanent procedure performed on (b)(6) 2019, in which one (1) freedom-8a receiver stimulator (fr8a-rcv-a0) and one (1) spare lead (fr8a-spr-b0) were implanted bilaterally at the thoracic nerve.The freedom scs system is not cleared for peripheral nerve stimulation by the therapeutic goods administration.However, the implanting clinician opted to continue with the implant by their own clinical judgement.The territory manager confirmed that the implant procedure was performed in a sterile environment, sterile field handling protocols were used, and the sterile barriers of all product used were intact prior to implant.The procedure was completed without complication, and the territory manager maintained contact with the patient following implant.On (b)(6) 2019, the patient contacted the territory manager to report irritation at the implant site.The patient reported the device was proximal to the surface of the skin and it was causing discomfort.The patient had imaging performed and confirmed the irritation was being cause by the devices that had moved closer to the surface of the skin.Further review of the patient's medical history demonstrated the patient's body is very twisted when walking, and it is likely this contributed to the patient's device moving towards the surface of the skin.The patient had a revision performed on (b)(6) 2019.The procedure was completed without complication.The root cause of the event is likely attributed to a combination of off-label placement of the device by the implanting clinician and patient physiology and movement.
|